The IHI incubator targets early-stage healthcare innovations, matching the venture's pre-seed stage and biopharma focus. However, the programme appears to be an incubator network rather than a direct grant, and the venture's AI/biotech drug resistance prediction may need to align with IHI's specific health technology themes. The EU geography and incubator format are suitable for the founder's Île-de-France base.